ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
16.99024
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,998.27
0.40%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Alemania
  5. TG
  6. Genmab AS (GE9)

  7. Genmab AS (GE9) Noticias

GE9 Genmab AS

260.80
2.40 (0.93%)
31 May 2024 - Cerrado
Datos en tiempo real
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Genmab AS GE9 Tradegate Acción Ordinaria
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
2.40 0.93% 260.80 16:50:06
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
258.90 258.20 261.00 260.80 258.40
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/6/202409:00GLOBEInvestigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in..
27/5/202409:16GLOBETransactions in Connection with Share Buy-back Program
23/5/202416:00GLOBEGenmab to Showcase Data in Various Patient Populations to be..
21/5/202410:06GLOBEGenmab Completes Acquisition of ProfoundBio
21/5/202406:19GLOBETransactions in Connection with Share Buy-back Program
14/5/202409:02GLOBEGenmab to Present New and Updated Results From Multiple..
13/5/202409:09GLOBETransactions in Connection with Share Buy-back Program
07/5/202413:27GLOBECapital Increase in Genmab as a Result of Employee Warrant..
06/5/202409:01GLOBETransactions in Connection with Share Buy-back Program
02/5/202410:01GLOBEGenmab Announces Financial Results for the First Quarter of..
29/4/202417:40GLOBETIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval..
29/4/202403:24GLOBETransactions in Connection with Share Buy-back Program..
22/4/202402:30GLOBETransactions in Connection with Share Buy-back Program..
16/4/202405:24GLOBEGenmab Announces Net Sales of DARZALEX® (daratumumab) for..
15/4/202403:07GLOBETransactions in Connection with Share Buy-back Program..
08/4/202404:44GLOBETransactions in Connection with Share Buy-back Program
03/4/202400:34GLOBEGenmab to Broaden and Strengthen Oncology Portfolio with..
02/4/202402:24GLOBETransactions in Connection with Share Buy-back Program
25/3/202408:30GLOBETransactions in Connection with Share Buy-back Program
18/3/202404:49GLOBECompletion of share buy-back program
15/3/202407:16GLOBEGenmab Announces Initiation of Share Buy-Back Program
13/3/202415:58GLOBETransactions with shares and linked securities in Genmab A/S..
13/3/202415:52GLOBEConstitution of the Board of Directors in Genmab A/S, Grant..
13/3/202410:13GLOBEPassing of Genmab A/S’ Annual General Meeting
11/3/202404:42GLOBETransactions in connection with share buy-back program
04/3/202412:10GLOBETransactions with shares and linked securities in Genmab A/S..
04/3/202403:29GLOBETransactions in connection with share buy-back program
01/3/202417:04GLOBETransactions with shares and linked securities in Genmab A/S..
29/2/202409:48GLOBETransactions with shares and linked securities in Genmab A/S..
27/2/202414:42GLOBETransactions with shares and linked securities in Genmab A/S..
27/2/202414:40GLOBECapital Increase in Genmab as a Result of Employee Warrant..
26/2/202418:45GLOBEU.S. FDA Accepts for Priority Review the Supplemental..
26/2/202404:21GLOBETransactions in connection with share buy-back program
23/2/202416:50GLOBETransactions with shares and linked securities in Genmab A/S..
23/2/202416:35GLOBEGrant of Restricted Stock Units to Management and Employees..
19/2/202403:40GLOBETransactions in connection with share buy-back program
15/2/202405:00GLOBENotice to Convene the Annual General Meeting of Genmab A/S
14/2/202413:09GLOBEGenmab Files Annual Report with the U.S. Securities and..
14/2/202410:41GLOBEGenmab Announces Initiation of Share Buy-Back Program
14/2/202410:02GLOBEGenmab Publishes 2023 Annual Report
02/2/202405:45GLOBETisotumab Vedotin Marketing Authorization Application..
25/1/202413:22GLOBEGrant of Restricted Stock Units and Warrants to Employees in..
23/1/202405:24GLOBEGenmab Announces Net Sales of DARZALEX® (daratumumab) for..
22/1/202417:40GLOBEGenmab Announces Decision in Arbitration Appeal under..
09/1/202405:45GLOBETIVDAK® (tisotumab vedotin-tftv) Supplemental Biologics..
02/1/202423:55GLOBETransactions With Shares and Linked Securities in Genmab A/S..
02/1/202408:52GLOBEGenmab to Present at the 42nd Annual J.P. Morgan Healthcare..
12/12/202306:00GLOBEGenmab to Hold 2023 R&D Update and ASH Data Review Meeting
09/12/202311:00GLOBENew Pivotal Data for Bispecific Antibody Epcoritamab..
05/12/202316:26GLOBECapital Increase in Genmab as a Result of Employee Warrant..

Su Consulta Reciente

TG
GE9
Genmab AS
COIN
AUCGBP
BIT
I05228
EURO STOXX Select Divide...
BIT
F28181
Vontobel Financial Produ...
BIT
P1D9Y9
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados